LifeMD, Inc. — Director's Dealing 2023

Jul 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-07-12

Reporting Person: Alvarez Nicholas P (Chief Acquisition Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-12	Common Stock	A	150000	—	Acquired	330000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-12	Employee Stock Option (Right to Buy)	$7.92	D	200000	Disposed		Common Stock (200000)	Direct

Footnotes

F1: The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020.